SNTI Stock Earnings Senti Biosciences Misses EPS for Q4 2023
SNTI Stock | USD 3.18 0.04 1.27% |
Under 60% of all Senti Biosciences' traders are looking to take a long position. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that some traders are interested. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Read at investorplace.com
![]() |
Senti Biosciences Current Investor Sentiment
Comfort Level 60
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Senti Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Senti Biosciences.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Senti Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Senti Biosciences Historical Investor Sentiment
Investor biases related to Senti Biosciences' public news can be used to forecast risks associated with an investment in Senti. The trend in average sentiment can be used to explain how an investor holding Senti can time the market purely based on public headlines and social activities around Senti Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Senti Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Senti Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Senti Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Senti Biosciences.
Senti Biosciences Fundamental Analysis
We analyze Senti Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Senti Biosciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Senti Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Senti Biosciences stock to make a market-neutral strategy. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics with similar companies.
Peers
Senti Biosciences Related Equities
CVKD | Cadrenal Therapeutics, | 9.62 | ||||
FHTX | Foghorn Therapeutics | 7.79 | ||||
XLO | Xilio Development | 7.42 | ||||
FENC | Fennec Pharmaceuticals | 4.58 | ||||
RAPT | RAPT Therapeutics | 3.70 | ||||
CNTB | Connect Biopharma | 2.74 | ||||
MLYS | Mineralys Therapeutics, | 1.72 | ||||
TYRA | Tyra Biosciences | 1.42 | ||||
QNRX | Quoin Pharmaceuticals | 0.65 | ||||
CING | Cingulate | 1.29 | ||||
LIPO | Lipella Pharmaceuticals | 2.24 | ||||
SABS | SAB Biotherapeutics | 4.64 | ||||
MNPR | Monopar Therapeutics | 6.04 |
Complementary Tools for Senti Stock analysis
When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |